As part of President Obama’s Precision Medicine Initiative, the Food and Drug Administration plans to launch a crowd-source platform to help develop standards for next generation testing technology that quickly sequences a person’s genome.

Planned for beta release in December, precisionFDA will offer researchers and test developers access to a secure cloud-hosted work space where their software code or data can be shared with collaborators, FDA, or even the public, if they so choose. According to the regulatory agency, precision medicine requires working collaboratively to ensure the accuracy of genetic tests in detecting and interpreting genetic variants.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access